SAFER Banking Act Sunday August 2 2026 Morning Analysis Cannabis Industry Watches Senate Calendar as Banking Reform Enters Critical August Legislative Window
TL;DR: The SAFER Banking Act — the most significant piece of cannabis-adjacent federal legislation currently advancing through Congress — has entered what industry lobbyists and Senate watchers describe as a critical window ahead of the August recess and fall legislative calendar. Bipartisan co-sponsorship has reached levels not seen in prior sessions, with Senate leadership signaling […]
TerrAscend Corp TSNDF Sunday August 2 2026 Morning Analysis Mid-Atlantic MSO Eyes Q2 2026 Earnings as Pennsylvania Adult-Use Market Matures and New Jersey Scale Drives Margin Recovery
TL;DR: TerrAscend Corp (OTC: TSNDF) heads into August earnings season as one of the more compelling mid-tier multi-state operator stories, with differentiated concentration in high-revenue adult-use markets along the Eastern Seaboard and a balance sheet that has stabilized materially over the past four quarters. Pennsylvania’s expanding adult-use legislative pathway and a maturing New Jersey footprint […]
WM Technology MAPS Saturday August 1 2026 Midday Analysis Weedmaps Digital Cannabis Marketplace Navigates Mature Market Headwinds With Nasdaq Delisting Enabling Strategic Flexibility Ahead of Q2 2026 Results
TL;DR: WM Technology (OTC: MAPS), parent of the Weedmaps cannabis marketplace, enters the Q2 2026 reporting window trading at $0.38 with positive free cash flow, a net cash position of $31.4 million, and a forward PE of 5.8x — a valuation that prices in structural revenue decline but may underweight the strategic optionality created by […]
Innovative Industrial Properties IIPR Saturday August 1 2026 Midday REIT Update Cannabis Infrastructure Landlord Eyes Q2 2026 Earnings With Revenue Inflection and 280E Tailwinds Reshaping Tenant Economics
TL;DR: Innovative Industrial Properties (IIPR) enters the August 2026 earnings window with Q1 2026 delivering its first year-over-year revenue growth in six quarters, aided by landmark Schedule III rescheduling that has materially improved economics for its medical cannabis tenant base. The cannabis REIT trades near $58.81 with a 12.9% dividend yield, offering institutional exposure to […]
Cannabis Sector Saturday August 1 2026 Morning Preview August Earnings Season Opens as 280E Tax Relief and Phase II Rescheduling Define Q2 Investment Thesis
TL;DR: The U.S. and Canadian cannabis sector’s most concentrated earnings window of 2026 opens this week, with Green Thumb Industries (GTBIF) reporting August 4 and Curaleaf (CURLF) and Aurora Cannabis (ACB) following on August 5, before Organigram (OGI) closes the window on August 11. Analysts are focused on a single macro question: is Schedule III’s […]
Tilray Brands TLRY Saturday August 1 2026 Morning Analysis Record FY2026 Revenue and Adjusted EBITDA Mark Milestone Year as Diversified Global Platform Eyes 1.2 Billion Run Rate
TL;DR: Tilray Brands (NASDAQ: TLRY) reported record fiscal 2026 results on July 29, posting $915.5 million in revenue — up 11% year-over-year — alongside record adjusted EBITDA of $61.1 million and a dramatically improved net loss of $105.2 million ($1.09/share) versus a $2.2 billion loss in fiscal 2025. The stock surged 8.10% to $4.54 on […]
Aurora Cannabis ACB Friday July 31 2026 End-of-Day Analysis Canadian Nasdaq LP Eyes August 5 Earnings Catalyst as YTD Outperformance and European Medical Pipeline Define Re-Rating Case
TL;DR: Aurora Cannabis (ACB) closes July 2026 on a constructive note, booking a year-to-date gain of approximately 34.5% while outperforming both the S&P/TSX Composite and the broader S&P 500. With Q4 FY2026 earnings scheduled for August 5 — coinciding with Curaleaf’s reporting date — ACB enters the August catalyst window as one of the sector’s […]
Organigram OGI Friday July 31 2026 LP Update Canadian LP Approaches August 11 Earnings with BAT Strategic Partnership and Near-Zero Leverage Defining Contrarian Investment Case
TL;DR: Organigram Global (Nasdaq: OGI) gained 3.27% to $0.9293 in Friday trading as the Canadian licensed producer approaches its estimated August 11, 2026 earnings release. Trading at 0.63x Price/Sales and 0.48x Price/Book with negligible leverage (debt-to-equity of 1.93%), Organigram represents one of the most compressed valuations in the global cannabis sector — underpinned by a […]
Curaleaf CURLF Friday July 31 2026 Midday Analysis Largest US MSO Approaches August 5 Earnings with Free Cash Flow Momentum and Balance Sheet Progress in Focus
TL;DR: Curaleaf Holdings (OTC: CURLF) trades at $9.46 ahead of its August 5, 2026 Q2 earnings release — the most anticipated reporting date in the cannabis MSO calendar this quarter. The largest US multi-state operator by revenue enters the earnings window generating positive free cash flow of $82.49M (TTM) while analyst consensus targets $15.00 per […]
Ascend Wellness Holdings AAWH Thursday July 30 2026 Evening Update Northeast MSO Eyes Q2 2026 Earnings as New York Adult-Use Maturation and New Jersey Scale Define August Catalyst Framework
TL;DR: Ascend Wellness Holdings (AAWH) enters the August earnings window with the northeast’s developing adult-use markets — particularly New York and New Jersey — providing the core operating context for its Q2 2026 performance assessment. The mid-tier multi-state operator’s concentrated exposure to the densely populated northeastern corridor positions it distinctively within the MSO landscape, with […]